BioSpace News Archive

Mirum Pharmaceuticals, Inc. announced that the Compensation Committee of Mirum’s Board of Directors granted non-qualified stock option awards to purchase an aggregate of 70,900 shares of common stock to four new employees under Mirum’s 2020 Inducement Plan.

The U.S. Food and Drug Administration continued to take action in the ongoing response to the COVID-19 pandemic

Lincoln International is pleased to announce that The Araz Group, Inc. (d/b/a HealthEZ), a leading independent third-party administrator (TPA) of self-funded medical plans, has received an investment from Abry Partners LP, a private investment firm focused on investing in and building market-leading middle market businesses